Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: Phase 2 basket study

Category Primary study
JournalJournal for ImmunoTherapy of Cancer
Year 2020
This article has no abstract
Epistemonikos ID: 62eaa795d6be3d8c8da540b48ffc78c796c23252
First added on: Feb 12, 2025